Literature DB >> 24117043

Significant involvement of nuclear factor-κB-inducing kinase in proper differentiation of αβ and γδ T cells.

Koji Eshima1, Motohito Okabe, Satoshi Kajiura, Haruka Noma, Nobukata Shinohara, Kazuya Iwabuchi.   

Abstract

Nuclear factor-κB-inducing kinase (NIK) is known to play a critical role in maintaining proper immune function. This is exemplified in the spontaneous mutant mouse lacking functional NIK, alymphoplasia (aly), which is simultaneously immune-compromised and autoimmune-prone. To investigate the role of NIK in αβ T-cell repertoire formation, we analysed T-cell development in aly/aly mice bearing a transgenic T-cell receptor (TCR). Although there were no apparent abnormalities in the mature αβ T cells of non-transgenic aly/aly mice, the maturation efficiency of idiotype(high+) T cells in the TCR-transgenic mice was lower in aly/aly mice compared with those found in aly/+ mice, suggesting that the mature αβ T-cell repertoire could be altered by the absence of functional NIK. In one strain of TCR-transgenic aly/aly mice with a negatively selecting H-2 background, the proportion of CD8(low+) idiotype(high+) cells, which are thought to potentially represent the γδ lineage of T cells, was markedly decreased. When the γδ T cells in non-transgenic aly/aly mice were investigated, the proportion of γδ T cells in the peripheral organs of aly/aly mice was found to be one-half to one-fifth of those in aly/+ mice. Analyses of bone marrow chimera mice indicated that NIK in host cells, rather than in donor cells was important for generating a normal number of peripheral γδ T cells. Collectively, these results suggest that NIK could be involved in thymic positive selection of some αβ T cells and that NIK in non-haematopoietic cells is important for the optimal development and/or maintenance of γδ T cells.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  T-cell receptor-transgenic mouse; nuclear factor-κB-inducing kinase; repertoire formation

Mesh:

Substances:

Year:  2014        PMID: 24117043      PMCID: PMC3904243          DOI: 10.1111/imm.12186

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  41 in total

1.  Inefficient ZAP-70 phosphorylation and decreased thymic selection in vivo result from inhibition of NF-kappaB/Rel.

Authors:  A L Mora; S Stanley; W Armistead; A C Chan; M Boothby
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

2.  The NF-kappa B-inducing kinase induces PC12 cell differentiation and prevents apoptosis.

Authors:  E D Foehr; J Bohuslav; L F Chen; C DeNoronha; R Geleziunas; X Lin; A O'Mahony; W C Greene
Journal:  J Biol Chem       Date:  2000-11-03       Impact factor: 5.157

3.  Evidence for CD8-independent T cell maturation in transgenic mice.

Authors:  J H Russell; P Meleedy-Rey; D E McCulley; W C Sha; C A Nelson; D Y Loh
Journal:  J Immunol       Date:  1990-05-01       Impact factor: 5.422

4.  Defective lymphotoxin-beta receptor-induced NF-kappaB transcriptional activity in NIK-deficient mice.

Authors:  L Yin; L Wu; H Wesche; C D Arthur; J M White; D V Goeddel; R D Schreiber
Journal:  Science       Date:  2001-03-16       Impact factor: 47.728

5.  Immunodeficiency of alymphoplasia mice (aly/aly) in vivo: structural defect of secondary lymphoid organs and functional B cell defect.

Authors:  U Karrer; A Althage; B Odermatt; H Hengartner; R M Zinkernagel
Journal:  Eur J Immunol       Date:  2000-10       Impact factor: 5.532

6.  A new mutation, aly, that induces a generalized lack of lymph nodes accompanied by immunodeficiency in mice.

Authors:  S Miyawaki; Y Nakamura; H Suzuka; M Koba; R Yasumizu; S Ikehara; Y Shibata
Journal:  Eur J Immunol       Date:  1994-02       Impact factor: 5.532

7.  The inter-relatedness and interdependence of mouse T cell receptor gammadelta+ and alphabeta+ cells.

Authors:  Daniel J Pennington; Bruno Silva-Santos; John Shires; Efstathios Theodoridis; Christopher Pollitt; Emma L Wise; Robert E Tigelaar; Michael J Owen; Adrian C Hayday
Journal:  Nat Immunol       Date:  2003-09-21       Impact factor: 25.606

8.  Essential role of NF-kappa B-inducing kinase in T cell activation through the TCR/CD3 pathway.

Authors:  Mitsuru Matsumoto; Takuji Yamada; Steven K Yoshinaga; Tom Boone; Tom Horan; Shigeru Fujita; Yi Li; Tasuku Mitani
Journal:  J Immunol       Date:  2002-08-01       Impact factor: 5.422

9.  NF-kappa B-inducing kinase establishes self-tolerance in a thymic stroma-dependent manner.

Authors:  Fumiko Kajiura; Shijie Sun; Takashi Nomura; Keisuke Izumi; Tomoo Ueno; Yoshimi Bando; Noriyuki Kuroda; Hongwei Han; Yi Li; Akemi Matsushima; Yousuke Takahama; Shimon Sakaguchi; Tasuku Mitani; Mitsuru Matsumoto
Journal:  J Immunol       Date:  2004-02-15       Impact factor: 5.422

10.  An unusual lineage of alpha/beta T cells that contains autoreactive cells.

Authors:  H von Boehmer; J Kirberg; B Rocha
Journal:  J Exp Med       Date:  1991-11-01       Impact factor: 14.307

View more
  4 in total

Review 1.  The non-canonical NF-κB pathway in immunity and inflammation.

Authors:  Shao-Cong Sun
Journal:  Nat Rev Immunol       Date:  2017-06-05       Impact factor: 53.106

2.  Differential dependence on nuclear factor-κB-inducing kinase among natural killer T-cell subsets in their development.

Authors:  Haruka Noma; Koji Eshima; Masashi Satoh; Kazuya Iwabuchi
Journal:  Immunology       Date:  2015-06-25       Impact factor: 7.397

3.  NF-κB-inducing kinase contributes to normal development of cortical thymic epithelial cells: its possible role in shaping a proper T-cell repertoire.

Authors:  Koji Eshima; Kana Misawa; Chihiro Ohashi; Haruka Noma; Kazuya Iwabuchi
Journal:  Immunology       Date:  2020-04-13       Impact factor: 7.397

4.  The NFκB-inducing kinase is essential for the developmental programming of skin-resident and IL-17-producing γδ T cells.

Authors:  Florian Mair; Stefanie Joller; Romy Hoeppli; Lucas Onder; Matthias Hahn; Burkhard Ludewig; Ari Waisman; Burkhard Becher
Journal:  Elife       Date:  2015-12-01       Impact factor: 8.140

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.